381 related articles for article (PubMed ID: 16776704)
1. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Krymchantowski AV; Filho PF; Bigal ME
Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
[TBL] [Abstract][Full Text] [Related]
2. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
4. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
5. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
Krymchantowski AV; Bigal ME
BMC Neurol; 2004 Jun; 4():10. PubMed ID: 15222892
[TBL] [Abstract][Full Text] [Related]
6. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
7. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
[TBL] [Abstract][Full Text] [Related]
8. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
Ng-Mak DS; Hu XH; Chen Y; Ma L; Solomon G
Int J Clin Pract; 2007 Jul; 61(7):1091-111. PubMed ID: 17537184
[TBL] [Abstract][Full Text] [Related]
9. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
Cady R; Martin V; Mauskop A; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2006 Jun; 46(6):914-24. PubMed ID: 16732837
[TBL] [Abstract][Full Text] [Related]
11. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
12. Migraine treatment with rizatriptan and almotriptan: a crossover study.
Ng-Mak DS; Hu XH; Bigal M
Headache; 2009 May; 49(5):655-62. PubMed ID: 19456878
[TBL] [Abstract][Full Text] [Related]
13. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
[TBL] [Abstract][Full Text] [Related]
14. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Krymchantowski AV; Barbosa JS
Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
Cutler NR; Jhee SS; Majumdar AK; McLaughlin D; Brucker MJ; Carides AD; Kramer MS; Matzura-Wolfe D; Reines SA; Goldberg MR
Headache; 1999 Apr; 39(4):264-9. PubMed ID: 15613223
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
20. Rizatriptan. Convenience and consistency.
Evans RW
Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
